Need Help? Call 1­-866-­796-­7386
« back to stock screener

  CLBS stock: Caladrius Biosciences Inc

Current Rating
Hold/Sell

Previous Rating:

Sell
Our Stock Ratings
double the S&P500!
Learn more.
Company Statistics
Price
$4.60
Market Cap
40.9M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
2.96
P/S
0.97
Dividend %
-
P/CF
-
P/FCF
-
Op. Cash Flow
-29K
FCF
-5.4
Op. Margin
-260.50%
Net Margin
-183.30%
ROE
-442.30%
ROI
-238.50%
ROA
-102.20%
EPS Growth
27.00%
Current Ratio
1.4
Debt/Equity
48.10%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Calmare Therapeutics Inc (CTTC) $0.10 - - 2.6M Strong Buy
Zynex Inc. (ZYXI) $0.31 - - 10.3M Strong Buy
MGC Diagnostics Corp (MGCD) $8.89 - - 42.8M Strong Buy
CRYO-CELL International, Inc. (CCEL) $4.64 - - 30.7M Strong Buy
ProPhase Labs Inc (PRPH) $2.00 - - 34.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More